MedRIC · 2004. 9. 6. · [Key words] Carboplatin, dosing method, AUC, renal functlon, body weight...

7

Transcript of MedRIC · 2004. 9. 6. · [Key words] Carboplatin, dosing method, AUC, renal functlon, body weight...

Page 1: MedRIC · 2004. 9. 6. · [Key words] Carboplatin, dosing method, AUC, renal functlon, body weight 1. Introduction Clsplatine cisplatin-Q- cisplatingl A} o carboplatinR_V01 * —9-1
Page 2: MedRIC · 2004. 9. 6. · [Key words] Carboplatin, dosing method, AUC, renal functlon, body weight 1. Introduction Clsplatine cisplatin-Q- cisplatingl A} o carboplatinR_V01 * —9-1
Page 3: MedRIC · 2004. 9. 6. · [Key words] Carboplatin, dosing method, AUC, renal functlon, body weight 1. Introduction Clsplatine cisplatin-Q- cisplatingl A} o carboplatinR_V01 * —9-1
Page 4: MedRIC · 2004. 9. 6. · [Key words] Carboplatin, dosing method, AUC, renal functlon, body weight 1. Introduction Clsplatine cisplatin-Q- cisplatingl A} o carboplatinR_V01 * —9-1
Page 5: MedRIC · 2004. 9. 6. · [Key words] Carboplatin, dosing method, AUC, renal functlon, body weight 1. Introduction Clsplatine cisplatin-Q- cisplatingl A} o carboplatinR_V01 * —9-1
Page 6: MedRIC · 2004. 9. 6. · [Key words] Carboplatin, dosing method, AUC, renal functlon, body weight 1. Introduction Clsplatine cisplatin-Q- cisplatingl A} o carboplatinR_V01 * —9-1
Page 7: MedRIC · 2004. 9. 6. · [Key words] Carboplatin, dosing method, AUC, renal functlon, body weight 1. Introduction Clsplatine cisplatin-Q- cisplatingl A} o carboplatinR_V01 * —9-1

Presentación de PowerPoint - forodebateoncologia.net · Options for first-line cisplatin-eligible patients Gemcitabine/ cisplatin MVAC or high-dose intensity MVAC Paclitaxel/ cisplatin

Presentación de PowerPoint - forodebateoncologia.net · Options for first-line cisplatin-eligible patients Gemcitabine/ cisplatin MVAC or high-dose intensity MVAC Paclitaxel/ cisplatin

Mechanisms of resistance to cisplatin and carboplatin · 14 D.J. Stewart / Critical Reviews in Oncology/Hematology 63 (2007) 12–31 Table 1 Mechanisms of resistance to platinums

Mechanisms of resistance to cisplatin and carboplatin · 14 D.J. Stewart / Critical Reviews in Oncology/Hematology 63 (2007) 12–31 Table 1 Mechanisms of resistance to platinums

BEATING CANCER SOONER...cancer drugs, including tamoxifen and Herceptin to treat breast cancer, carboplatin and cisplatin to treat lung, ovarian and testicular cancers, abiraterone

BEATING CANCER SOONER...cancer drugs, including tamoxifen and Herceptin to treat breast cancer, carboplatin and cisplatin to treat lung, ovarian and testicular cancers, abiraterone

PowerPoint Presentation€¦ · Oropharynx, Hypopharynx Treatment Landscape Advanced HNSCC TPF 62% Carboplatin + XRT PF Carboplatin + XRT TPF = Docetaxel, Cisplatin, 5-Fluorouracil

PowerPoint Presentation€¦ · Oropharynx, Hypopharynx Treatment Landscape Advanced HNSCC TPF 62% Carboplatin + XRT PF Carboplatin + XRT TPF = Docetaxel, Cisplatin, 5-Fluorouracil

Traitement du cancer du poumon métastatique€¦ · Platines (carboplatin, cisplatin) ... Carbo-Gem Carbo-Taxol Carbo-Vino Carbo-Gem Carbo-Taxol Carbo-Vino PAS d’ALIMTA 1ere: platine

Traitement du cancer du poumon métastatique€¦ · Platines (carboplatin, cisplatin) ... Carbo-Gem Carbo-Taxol Carbo-Vino Carbo-Gem Carbo-Taxol Carbo-Vino PAS d’ALIMTA 1ere: platine

Adjuvant Chemotherapy for NSCLC: 2019 · Regimen • cisplatin/vinorelbine - most studied, regimen used in the 2 positive studies (JBR10, ANITA) • carboplatin used when cisplatin

Adjuvant Chemotherapy for NSCLC: 2019 · Regimen • cisplatin/vinorelbine - most studied, regimen used in the 2 positive studies (JBR10, ANITA) • carboplatin used when cisplatin

BIOLOGICAL BEHAVIOR OF QUINAZOLIN-4(3 H)-ONE DERIVATIVE BASED PLATINUM… · 2020. 5. 15. · IAlthough platinum metallo-anticancer drugs such as cisplatin, carboplatin, ... -4(3H)-ones

BIOLOGICAL BEHAVIOR OF QUINAZOLIN-4(3 H)-ONE DERIVATIVE BASED PLATINUM… · 2020. 5. 15. · IAlthough platinum metallo-anticancer drugs such as cisplatin, carboplatin, ... -4(3H)-ones

OVARIAN CANCER...Treatment to Relapse Second-Line Therapy (months) (%) 0 – 6 10 7 – 12 29 13 – 18 63 19 – 24 94 SALVAGE THERAPY FOR OVARIAN CANCER Platinum (carboplatin, cisplatin)

OVARIAN CANCER...Treatment to Relapse Second-Line Therapy (months) (%) 0 – 6 10 7 – 12 29 13 – 18 63 19 – 24 94 SALVAGE THERAPY FOR OVARIAN CANCER Platinum (carboplatin, cisplatin)

Cisplatin discussion

Cisplatin discussion

GOG0172: The Dings The recommended regimen is not feasible –Substitution of carboplatin for cisplatin –Reduce cisplatin from 100 mg/m 2 to 75 mg/m 2 –Change.

GOG0172: The Dings The recommended regimen is not feasible –Substitution of carboplatin for cisplatin –Reduce cisplatin from 100 mg/m 2 to 75 mg/m 2 –Change.

New Research Evaluating Cisplatin Uptake in Ovarian … · New Research Evaluating Cisplatin Uptake in Ovarian ... Mass Spectrometry. 2 ... New Research Evaluating Cisplatin Uptake

New Research Evaluating Cisplatin Uptake in Ovarian … · New Research Evaluating Cisplatin Uptake in Ovarian ... Mass Spectrometry. 2 ... New Research Evaluating Cisplatin Uptake

CARBOPLATIN 10 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION ... · MHRA-UKPAR – Carboplatin 10 mg/ml Concentrate for Solution for Infusion PL 08137/0150-2 -1 - CARBOPLATIN 10 MG/ML

CARBOPLATIN 10 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION ... · MHRA-UKPAR – Carboplatin 10 mg/ml Concentrate for Solution for Infusion PL 08137/0150-2 -1 - CARBOPLATIN 10 MG/ML

Optimierung der Therapie von Patienten mit Keimzelltumoren ... · • Carboplatin statt Cisplatin - "no go" Feldman, JAMA 2008 Einhorn, ASCO 2009 . Kein Bleomycin • Vorbestehende

Optimierung der Therapie von Patienten mit Keimzelltumoren ... · • Carboplatin statt Cisplatin - "no go" Feldman, JAMA 2008 Einhorn, ASCO 2009 . Kein Bleomycin • Vorbestehende

Phase-III Studie: HECTOR Topotecan plus Carboplatin (Paclitaxel plus Carboplatin oder Gemcitabin plus Carboplatin) -Intergroup Study of NOGGO und Studiengruppe.

Phase-III Studie: HECTOR Topotecan plus Carboplatin (Paclitaxel plus Carboplatin oder Gemcitabin plus Carboplatin) -Intergroup Study of NOGGO und Studiengruppe.

HIGHLIGHTS OF PRESCRIBING INFORMATION --------------------- … · 2020. 11. 18. · Small Cell Lung Cancer . IMFINZI, in combination with etoposide and either carboplatin or cisplatin,

HIGHLIGHTS OF PRESCRIBING INFORMATION --------------------- … · 2020. 11. 18. · Small Cell Lung Cancer . IMFINZI, in combination with etoposide and either carboplatin or cisplatin,

Colon Oral Cisplatin

Colon Oral Cisplatin

Carboplatin & Pegylated Liposomal Doxorubicin (PLD) versus Carboplatin & Paclitaxel in Relapsed, Platinum-sensitive Ovarian Cancer Eric Pujade-Lauraine.

Carboplatin & Pegylated Liposomal Doxorubicin (PLD) versus Carboplatin & Paclitaxel in Relapsed, Platinum-sensitive Ovarian Cancer Eric Pujade-Lauraine.

ESMO E-Learning: Management of Advanced NSCLC: …oncologypro.esmo.org/content/download/38068/749531/file/managemen… · cancer (NSCLC) cisplatin or carboplatin combination therapies

ESMO E-Learning: Management of Advanced NSCLC: …oncologypro.esmo.org/content/download/38068/749531/file/managemen… · cancer (NSCLC) cisplatin or carboplatin combination therapies

Cisplatin versus carboplatin in combination with third ... · Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer Tiago

Cisplatin versus carboplatin in combination with third ... · Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer Tiago

Evidence-Based Systematic Review (EBSR): Drug-Induced ... · target aminoglycosides (e.g., loop diuretics, carboplatin, cisplatin, isepamicin, etc.) or because the original data were

Evidence-Based Systematic Review (EBSR): Drug-Induced ... · target aminoglycosides (e.g., loop diuretics, carboplatin, cisplatin, isepamicin, etc.) or because the original data were